/channels/news_feeds/all/term/active_start_ups/rss en /channels/channels/news/active-startup-ananda-301481 <div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even"><p><strong>Business Snapshot</strong><br /> The company manufactures microfluidic platforms for the diagnostics and biomedical research markets. The technology increases the standardization, precision and reproducibility of cell assays and can be integrated with sensors and electronic devices in order to acquire, store and manage data at a single cell level.</p> <p><strong>Target Markets</strong><br /> Diagnostics and biomedical research markets</p> <p><strong>Intellectual Property</strong><br /> In prosecution.</p> <p><strong>Founder</strong><br /> Margaret Magdesian</p> </div></div></div><div class="field field-name-field-primary-image field-type-image field-label-hidden"><div class="field-items"><div class="field-item even"><img class="no-float" src="/channels/files/channels/styles/wysiwyg_medium/public/channels/image/picture1.png?itok=b365Op48" width="160" height="133" alt="" /></div></div></div><div class="field field-name-field-published-date field-type-datestamp field-label-hidden"><div class="field-items"><div class="field-item even"><div class="custom-multi-date"><div class="multi-date first"><span class="label">Published: </span><span class="day">10 </span><span class="month">October </span><span class="year">2019</span></div></div></div></div></div> Thu, 10 Oct 2019 14:49:47 +0000 webfull 154221 at /channels /channels/channels/news/active-startup-aum-lifetech-ltd-301482 <div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even"><p><strong>Business Snapshot</strong><br /> Company produces/distributes proprietary FANA oligonucleotides with unique advantages in industrial scale quantities based on proprietary oligonucleotide production methods.</p> <p><strong>Target Markets</strong><br /> FANA technology can be used for discovery, translation, and potentially for therapeutic development. Company is working with collaborators for therapeutic development for a wide spectrum of genetic diseases as well as making RNA silencing and regulation available to biomedical researchers across the globe.</p></div></div></div><div class="field field-name-field-primary-image field-type-image field-label-hidden"><div class="field-items"><div class="field-item even"><img class="no-float" src="/channels/files/channels/styles/wysiwyg_medium/public/channels/image/picture2.png?itok=TKJfzEZB" width="160" height="240" alt="" /></div></div></div><div class="field field-name-field-published-date field-type-datestamp field-label-hidden"><div class="field-items"><div class="field-item even"><div class="custom-multi-date"><div class="multi-date first"><span class="label">Published: </span><span class="day">10 </span><span class="month">October </span><span class="year">2019</span></div></div></div></div></div> Thu, 10 Oct 2019 14:49:12 +0000 webfull 154220 at /channels /channels/channels/news/active-startup-corbin-therapeutics-inc-301484 <div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even"><p><strong>Business Snapshot</strong><br /> Using a unique drug discovery platform to identify and develop novel inhibitors for treatment of various inflammation diseases, such as multiple sclerosis. This platform includes several in-vitro and in-vivo models for efficient drug screening and confirmation of potential lead candidates.</p> <p><strong>Target Markets</strong><br /> Inflammation (neuro-inflammation in particular)</p> <p><strong>Intellectual Property</strong><br /> Granted in Europe, in prosecution elsewhere.</p> <p><strong>Founder</strong><br /> Philippe Gros</p> </div></div></div><div class="field field-name-field-primary-image field-type-image field-label-hidden"><div class="field-items"><div class="field-item even"><img class="no-float" src="/channels/files/channels/styles/wysiwyg_medium/public/channels/image/picture3.png?itok=CXh89Yzx" width="145" height="144" alt="" /></div></div></div><div class="field field-name-field-published-date field-type-datestamp field-label-hidden"><div class="field-items"><div class="field-item even"><div class="custom-multi-date"><div class="multi-date first"><span class="label">Published: </span><span class="day">10 </span><span class="month">October </span><span class="year">2019</span></div></div></div></div></div> Thu, 10 Oct 2019 14:48:34 +0000 webfull 154219 at /channels /channels/channels/news/active-startup-iaso-biomed-inc-301525 <div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even"><p><strong>Business Snapshot</strong><br /> Developing a drug that is an alternative to testosterone replacement therapy. The drug stimulates the body's own production of testosterone rather than using synthetic hormones and steroids.</p> <p><strong>Target Markets</strong><br /> Testosterone market (men's health)</p> <p><strong>Intellectual Property</strong><br /> In prosecution in the United States, Europe, India, and Australia.</p> <p><strong>Founders</strong><br /> Vassilios Papadopoulos, Costas Karatzas, Duane Knight, Jr., Richard Schell</p> </div></div></div><div class="field field-name-field-primary-image field-type-image field-label-hidden"><div class="field-items"><div class="field-item even"><img class="no-float" src="/channels/files/channels/styles/wysiwyg_medium/public/channels/image/picture18.png?itok=JxaGxkdr" width="110" height="54" alt="" /></div></div></div><div class="field field-name-field-published-date field-type-datestamp field-label-hidden"><div class="field-items"><div class="field-item even"><div class="custom-multi-date"><div class="multi-date first"><span class="label">Published: </span><span class="day">10 </span><span class="month">October </span><span class="year">2019</span></div></div></div></div></div> Thu, 10 Oct 2019 14:47:43 +0000 webfull 154218 at /channels /channels/channels/news/active-startup-invicare-301523 <div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even"><p><strong>Business Snapshot</strong><br /> Company possesses technology that addresses the problem of dental implant infections and failure, using innovative and proprietary inorganic crystalline hydrogels.</p> <p> </p> <p><strong>Target Markets</strong><br /> Dental and implants.</p> <p><strong>Intellectual Property</strong><br /> Patents pending in Canada, US, Europe.</p> <p><strong>Founders</strong><br /> Faleh Marino Tamimi, Ashwaq Al-Hashedi</p> </div></div></div><div class="field field-name-field-primary-image field-type-image field-label-hidden"><div class="field-items"><div class="field-item even"><img class="no-float" src="/channels/files/channels/styles/wysiwyg_medium/public/channels/image/picture17.png?itok=dAzVdhmc" width="160" height="51" alt="" /></div></div></div><div class="field field-name-field-published-date field-type-datestamp field-label-hidden"><div class="field-items"><div class="field-item even"><div class="custom-multi-date"><div class="multi-date first"><span class="label">Published: </span><span class="day">10 </span><span class="month">October </span><span class="year">2019</span></div></div></div></div></div> Thu, 10 Oct 2019 14:45:29 +0000 webfull 154216 at /channels /channels/channels/news/active-startup-kanyr-pharma-301522 <div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even"><p><strong>Business Snapshot</strong><br /> Kanyr has proprietary data on their mechanism of action and a proprietary small molecule lead compound inhibitor allowing for the targeting of phosphatases of regenerating liver (PRLs) through a newly identified co-oncogenic partner.</p> <p><strong>Target Markets</strong><br /> Immunotherapy (cancer).</p> <p><strong>Intellectual Property</strong><br /> In prosecution in Canada, US, Europe, Japan, China.</p> <p><strong>Founder</strong><br /> Michel Tremblay</p> </div></div></div><div class="field field-name-field-primary-image field-type-image field-label-hidden"><div class="field-items"><div class="field-item even"><img class="no-float" src="/channels/files/channels/styles/wysiwyg_medium/public/channels/image/picture16.png?itok=SrfjSDvr" width="160" height="51" alt="" /></div></div></div><div class="field field-name-field-published-date field-type-datestamp field-label-hidden"><div class="field-items"><div class="field-item even"><div class="custom-multi-date"><div class="multi-date first"><span class="label">Published: </span><span class="day">10 </span><span class="month">October </span><span class="year">2019</span></div></div></div></div></div> Thu, 10 Oct 2019 14:43:14 +0000 webfull 154215 at /channels /channels/channels/news/active-startup-laurent-pharma-301521 <div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even"><p><strong>Business Snapshot</strong><br /> Company has developed a clinical stage, orally-active drug candidate with the potential to modulate the immuno-inflammatory response in cystic fibrosis patients.</p> <p><strong>Target Markets</strong><br /> Cystic fibrosis</p> <p><strong>Intellectual Property</strong><br /> Patents around the world</p> <p><strong>Founder</strong><br /> Danuta Radzioch, Radu Pislariu</p> </div></div></div><div class="field field-name-field-primary-image field-type-image field-label-hidden"><div class="field-items"><div class="field-item even"><img class="no-float" src="/channels/files/channels/styles/wysiwyg_medium/public/channels/image/picture15.png?itok=sZZtoPTd" width="160" height="55" alt="" /></div></div></div><div class="field field-name-field-published-date field-type-datestamp field-label-hidden"><div class="field-items"><div class="field-item even"><div class="custom-multi-date"><div class="multi-date first"><span class="label">Published: </span><span class="day">10 </span><span class="month">October </span><span class="year">2019</span></div></div></div></div></div> Thu, 10 Oct 2019 14:40:36 +0000 webfull 154214 at /channels /channels/channels/news/active-startup-mimetogen-pharma-301518 <div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even"><p><strong>Business Snapshot</strong><br /> Mimetogen Pharmaceuticals is a clinical stage biotechnology company focused on developing the use of peptidomimetics as a novel approach to treating ophthalmic diseases.</p> <p><strong>Target Markets</strong><br /> Dry eye</p> <p><strong>Intellectual Property</strong><br /> Patents around the world</p> <p><strong>Founder</strong><br /> Uri Saragovi</p> </div></div></div><div class="field field-name-field-primary-image field-type-image field-label-hidden"><div class="field-items"><div class="field-item even"><img class="no-float" src="/channels/files/channels/styles/wysiwyg_medium/public/channels/image/picture13.png?itok=Adj9KklZ" width="160" height="40" alt="" /></div></div></div><div class="field field-name-field-published-date field-type-datestamp field-label-hidden"><div class="field-items"><div class="field-item even"><div class="custom-multi-date"><div class="multi-date first"><span class="label">Published: </span><span class="day">10 </span><span class="month">October </span><span class="year">2019</span></div></div></div></div></div> Thu, 10 Oct 2019 14:35:18 +0000 webfull 154211 at /channels /channels/channels/news/active-startup-molecular-forecaster-301493 <div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even"><p><strong>Business Snapshot</strong><br /> Two user-focused platforms, FORECASTER and VIRTUAL CHEMIST, are used for drug discovery, metabolism prediction, combinatorial chemistry, and asymmetric catalyst design.</p> <p><strong>Target Markets</strong><br /> Pharmaceutical companies with drug discovery capabilities and fine chemical manufacturers.</p> <p><strong>Intellectual Property</strong><br /> Proprietary software is copyrighted.</p> <p><strong>Founders</strong><br /> Nicolas Moitessier, Eric Therrien</p> </div></div></div><div class="field field-name-field-primary-image field-type-image field-label-hidden"><div class="field-items"><div class="field-item even"><img class="no-float" src="/channels/files/channels/styles/wysiwyg_medium/public/channels/image/picture12.jpg?itok=pmzfBsbM" width="160" height="57" alt="" /></div></div></div><div class="field field-name-field-published-date field-type-datestamp field-label-hidden"><div class="field-items"><div class="field-item even"><div class="custom-multi-date"><div class="multi-date first"><span class="label">Published: </span><span class="day">9 </span><span class="month">October </span><span class="year">2019</span></div></div></div></div></div> Wed, 09 Oct 2019 21:38:27 +0000 webfull 154185 at /channels /channels/channels/news/active-startup-nexplasmagen-301491 <div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even"><p><strong>Business Snapshot</strong><br /> The company manufactures a low temperature plasma device for biomedical applications. For cancer applications, the technology will kill cancer cells while avoiding the surrounding healthy tissue.</p> <p><strong>Target Markets</strong><br /> Oncology, specifically breast cancer.</p> <p><strong>Intellectual Property</strong><br /> Granted patents in the US and Canada</p> <p><strong>Founders</strong><br /> Valérie Léveillé</p> </div></div></div><div class="field field-name-field-primary-image field-type-image field-label-hidden"><div class="field-items"><div class="field-item even"><img class="no-float" src="/channels/files/channels/styles/wysiwyg_medium/public/channels/image/picture10.png?itok=Hc911uM6" width="139" height="90" alt="" /></div></div></div><div class="field field-name-field-published-date field-type-datestamp field-label-hidden"><div class="field-items"><div class="field-item even"><div class="custom-multi-date"><div class="multi-date first"><span class="label">Published: </span><span class="day">9 </span><span class="month">October </span><span class="year">2019</span></div></div></div></div></div> Wed, 09 Oct 2019 21:32:50 +0000 webfull 154183 at /channels